eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Share:
Send email
Share:
Original paper

Freiburg flap used as vaginal applicator with/without free-hand interstitial needles in three-dimensional high-dose-rate brachytherapy for vaginal stump recurrence of cervical cancer

Mingyuan He
1
,
Hongfu Zhao
1
,
Yuqing Zhang
1
,
Ning Zhang
1
,
Zhipeng Zhao
1
,
Guanghui Cheng
1

  1. Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun 130033, China
J Contemp Brachytherapy 2024; 16
DOI: https://doi.org/10.5114/jcb.2024.144531
Online publish date: 2024/10/29
Article file
- Freiburg flap used.pdf  [0.82 MB]
Get citation
 
 
1. Shen XR, Feng R, Chai J et al. Modeling age-specific cancer incidences using logistic growth equations: implications for data collection. Asian Pac J Cancer Prev 2014; 15: 9731-9737.
2. NCCN Clinical Practice Guidelines for cervical cancer. Available at:. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf (accessed May 6 2024).
3. Nakayama K, Teshima H, Hirai Y et al. Stump recurrence after radical hysterectomy for patients with uterine cervical cancer. Nihon Sanka Fujinka Gakkai Zasshi 1990; 42: 241-245.
4. He Y, Wu Y, Zhao Q et al. Clinical analysis of patients underwent hysterectomy for stage I cervical cancer or high grade cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia. Zhonghua Fu Chan Ke Za Zhi 2015; 50: 516-521.
5. Ito H, Kumagaya H, Shigematsu N et al. High dose rate intracavitary brachytherapy for recurrent cervical cancer of the vaginal stump following hysterectomy. Int J Radiat Oncol Biol Phys 1991; 20: 927-932.
6. Lin Y, Zhou J, Dai L et al. Vaginectomy and vaginoplasty for isolated vaginal recurrence 8 years after cervical cancer radical hysterectomy: A case report and literature review. J Obstet Gynaecol Res 2017; 43: 1493-1497.
7. Abe A, Matoda M, Okamoto S et al. Resection of the vaginal vault for vaginal recurrence of cervical cancer after hysterectomy and brachytherapy. World J Surg Oncol 2015; 13: 137.
8. Nemoto Murofushi K, Tanaka R, Ohkawa A et al. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation. J Contemp Brachytherapy 2022; 14: 60-65.
9. Engineer R, Chopra S, Shukla R et al. Computed tomography-based interstitial brachytherapy for recurrent cervical carcinoma in the vaginal apex. Clin Oncol 2022; 34: e1-e6.
10. Chapman CH, Cunha AJ, Littell RD et al. High-dose-rate interstitial brachytherapy for vaginal endometrial cancer recurrence after prior surgery and radiotherapy. Brachytherapy 2021; 20: 536-542.
11. Yan J, Qin X, Zhang F et al. Comparing multichannel cylinder and 3D-printed applicators for vaginal cuff brachytherapy with preliminary exploration of post-hysterectomy vaginal morphology. J Contemp Brachytherapy 2021; 13: 641-648.
12. Zhao Z, Tang X, Mao Z, Zhao H. The design of an individualized cylindrical vaginal applicator with oblique guide holes using 3D modeling and printing technologies. J Contemp Brachytherapy 2019; 11: 479-487.
13. Qin X, Zhang F, Hou X et al. Efficacy and safety of a 3D-printed applicator for vaginal brachytherapy in patients with central pelvic-recurrent cervical cancer after primary hysterectomy. Brachytherapy 2022; 21: 193-201.
14. Mao Z, Zhao H. 3D-printed vaginal cylindrical template with curved needle channels in MRI-guided vaginal cuff brachytherapy. J Contemp Brachytherapy 2023; 15: 422-431.
15. Guthier CV, Devlin PM, Harris TC et al. Development and clinical implementation of semi-automated treatment planning including 3D printable applicator holders in complex skin brachytherapy. Med Phys 2020; 47: 869-879.
16. Goodman CD, Mendez LC, Velker V et al. 3D image-guided interstitial brachytherapy for primary vaginal cancer: A multi-institutional experience. Gynecol Oncol 2021; 160: 134-139.
17. Kim D, Buzurovic I, Mahal B et al. Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand. J Contemp Brachytherapy 2020; 12: 48-52.
18. Pierquin B, Dutreix A, Paine CH et al. The Paris system in interstitial radiation therapy. Acta Radiologica 2009; 17: 33-48.
19. Lin Y, Shi D, Li H et al. Application of transrectal ultrasound in guiding interstitial brachytherapy for advanced cervical cancer. J Contemp Brachytherapy 2020; 12: 375-382.
20. Pötter R, Haie-Meder C, Van Limbergen E et al., Group GEW. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77.
21. Haie-Meder C, Pötter R, Van Limbergen E et al. Gynaecological GECEWG. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-245.
22. Pötter R, Tanderup K, Kirisits C et al., EMBRACE Collaborative Group. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9: 48-60.
23. Ito H, Shigematsu N, Kawada T et al. Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy. Gynecol Oncol 1997; 67: 154-161.
24. Takamizawa H, Kasai T, Arai T. Treatment of recurrent cervical cancer. Gan No Rinsho 1983; 29: 1079-1084.
25. Pötter R, Tanderup K, Schmid MP et al., EMBRACE Collaborative Group. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 2021; 22: 538-547.
26. Han K, Milosevic M, Fyles A et al. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys 2013; 87: 111-119.
27. Han K, Colson-Fearon D, Liu Z, Viswanathan A. Updated trends in the utilization of brachytherapy in cervical cancer in the United States: A surveillance, epidemiology, and end-results study. Int J Radiat Oncol Biol Phys 2024; 119: 143-153.
28. Koumantakis E, Haralambakis Z, Koukourakis M et al. A pilot study on concurrent platinum chemotherapy and intracavitary brachytherapy for locally advanced cancer of the uterine cervix. Br J Radiol 1998; 71: 552-557.
29. Chopra S, Engineer R, Shah S et al. MRI- and PET-guided interstitial brachytherapy for postsurgical vaginal recurrences of cervical cancer: Results of phase II study. Int J Radiat Oncol Biol Phys 2020; 106: 310-319.
30. Nag S, Erickson B, Thomadsen E et al., American Brachytherapy Society. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48: 201-211.
31. Li F, Lu S, Zhao H et al. Three-dimensional image-guided combined intracavitary and interstitial high-dose-rate brachytherapy in cervical cancer: A systematic review. Brachytherapy 2021; 20: 85-94.
32. Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991; 21: 1425-1434.
33. Orton CG. High and low dose-rate brachytherapy for cervical carcinoma. Acta Oncol 2009; 37: 117-125.
34. Kirisits C, Pötter R, Lang S et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005; 62: 901-911.
35. Chen J, Zhang N, Liu Y et al. Analysis of applicator insertion related acute side effects for cervical cancer treated with brachytherapy. Front Oncol 2021; 11: 677052.
36. Cheng G, Mu X, Liu Y et al. Predictive value of Excel forms based on an automatic calculation of dose equivalent in 2 Gy per fraction in adaptive brachytherapy for cervical cancer. J Contemp Brachytherapy 2020; 12: 454-461.
37. Wu N, Bu M, Jiang H et al. Dose-effect relationship in external beam radiotherapy combined with brachytherapy for cervical cancer: a systematic review. J Contemp Brachytherapy 2024; 16: 232-240.
38. Tang X, Mu X, Zhao Z et al. Dose-effect response in image-guided adaptive brachytherapy for cervical cancer: A systematic review and meta-regression analysis. Brachytherapy 2020; 19: 438-446.
39. Li F, Shi D, Bu M et al. Four-dimensional image-guided adaptive brachytherapy for cervical cancer: A systematic review and meta-regression analysis. Front Oncol 2022; 12: 870570.
40. Zanagnolo V, Minig LA, Gadducci A et al. Surveillance procedures for patients for cervical carcinoma: a review of the literature. Int J Gynecol Cancer 2009; 19: 306-313.
41. Wang K, Qu A, Deng X et al. Efficacy and safety of 3-dimensional printing noncoplanar template (3D-PNCT)-assisted high-dose-rate interstitial brachytherapy (HDR-ISBT) for reirradiation of recurrent cervical cancer: a prospective cohort. J Gynecol Oncol 2024.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.